Strides Arcolab surges on reporting stellar Q2 numbers

07 Nov 2014 Evaluate

Strides Arcolab is currently trading at Rs. 678.00, up by 11.35 points or 1.70% from its previous closing of Rs. 666.65 on the BSE.

The scrip opened at Rs. 672.75 and has touched a high and low of Rs. 691.90 and Rs. 668.80 respectively. So far 75567 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 1050.00 on 05-Dec-2013 and a 52 week low of Rs. 343.80 on 26-Feb-2014.

Last one week high and low of the scrip stood at Rs. 691.90 and Rs. 662.00 respectively. The current market cap of the company is Rs. 4050.46 crore.

The promoters holding in the company stood at 27.67% while Institutions and Non-Institutions held 46.79% and 25.54% respectively.

Strides Arcolab has reported a net profit after tax of Rs 338.47 crore for the quarter under review as compared to Rs 2.21 crore for the same quarter in the previous year. Total income of the company has increased by 8.24% at Rs 244.04 crore for Q2FY15 as compared Rs 225.47 crore for the corresponding quarter previous year.

Strides Arcolab is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables.

Strides Pharma Scien Share Price

890.95 3.85 (0.43%)
11-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1806.90
Dr. Reddys Lab 1272.95
Cipla 1512.10
Zydus Lifesciences 922.45
Lupin 2080.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×